Habte Yimer, MD Hematologist/Oncologist, US Oncology Research Executive Council Member, Texas Oncology, discusses The Future Of Anti-BCMA CAR-T Cell Therapy. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Habte Yimer, MD Hematologist/Oncologist, US Oncology Research Executive Council Member, Texas Oncology, discusses The Future Of Anti-BCMA CAR-T Cell Therapy. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com